Department of surgery, Faculty of Medicine, Shahed University, Tehran, Iran.
Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
J Prev Med Hyg. 2024 Aug 31;65(2):E214-E220. doi: 10.15167/2421-4248/jpmh2024.65.2.3270. eCollection 2024 Jun.
Osteoarthritis (OA) is one of the most common degenerative joint diseases which involved all joints. It is very important to choose a treatment method with high efficiency to reduce the pain and disability of patients and also to improve their quality of life. The current study aimed to investigate the therapeutic effects of intra-articular injection of PRP and hyaluronic acid (HA) in the knee of people with knee osteoarthritis (KOA).
In this randomized clinical trial study, 90 patients with KOA were randomly divided into two groups of intra-articular HA and PRP. The patients of the two groups were followed up for five months and different outcomes were recorded. The McMaster index (WOMAC) evaluated all patients at rest and during movements. Measurements were taken at the beginning and after the third month of follow-up.
Three month after the last injection (5th month) and after adjusting of baseline value using analysis of covariance, the mean of knee pain, stiffness, physical function and finally total score in the PRP group, was significantly lower than the HA group. Regarding the Osteoarthritis grade, the mean of knee pain, Stiffness, Physical function and finally total score in the PRP group was significantly lower than the HA group in all Osteoarthritis grades. Also, there were no complications in the studied groups.
The results of the current study showed that pain and stiffness reduction as well as physical function of the knee joint in the PRP group was better than in the HA group.
骨关节炎(OA)是一种最常见的退行性关节疾病,涉及所有关节。选择一种高效的治疗方法来减轻患者的疼痛和残疾,提高他们的生活质量非常重要。本研究旨在探讨关节内注射富血小板血浆(PRP)和透明质酸(HA)治疗膝骨关节炎(KOA)的疗效。
本随机临床试验研究将 90 例 KOA 患者随机分为关节内 HA 和 PRP 两组。两组患者均随访 5 个月,并记录不同的结果。麦马斯特指数(WOMAC)评估所有患者在休息和运动时的情况。在随访开始和第 3 个月时进行测量。
末次注射后 3 个月(第 5 个月),采用协方差分析校正基线值后,PRP 组的膝关节疼痛、僵硬、躯体功能和总评分均值明显低于 HA 组。在所有骨关节炎分级中,PRP 组的膝关节疼痛、僵硬、躯体功能和总评分均值均明显低于 HA 组。此外,两组均无并发症。
本研究结果表明,PRP 组在减轻疼痛、改善膝关节僵硬和提高膝关节功能方面优于 HA 组。